Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
11.30
+0.04 (0.36%)
At close: Jun 27, 2025, 4:00 PM
11.22
-0.08 (-0.71%)
After-hours: Jun 27, 2025, 7:44 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $1.01 billion as of June 27, 2025. Its market cap has increased by 124.25% in one year.
Market Cap
1.01B
Enterprise Value
580.79M
1-Year Change
124.25%
Ranking
Category
Stock Price
$11.30
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has increased from $869.34M to $1.01B, an increase of 16.09%. That is a compound annual growth rate of 3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.01B | 110.53% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 703.29B |
| Johnson & Johnson | 368.18B |
| AbbVie | 328.62B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.85B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.56B |
| AstraZeneca | 215.99B |